These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 30089638

  • 1. Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies.
    VanDerMeid KR, Elliott MR, Baran AM, Barr PM, Chu CC, Zent CS.
    Cancer Immunol Res; 2018 Oct; 6(10):1150-1160. PubMed ID: 30089638
    [Abstract] [Full Text] [Related]

  • 2. Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia.
    Cheney CM, Stephens DM, Mo X, Rafiq S, Butchar J, Flynn JM, Jones JA, Maddocks K, O'Reilly A, Ramachandran A, Tridandapani S, Muthusamy N, Byrd JC.
    MAbs; 2014 Oct; 6(3):749-55. PubMed ID: 24594909
    [Abstract] [Full Text] [Related]

  • 3. Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies.
    Tipton TR, Roghanian A, Oldham RJ, Carter MJ, Cox KL, Mockridge CI, French RR, Dahal LN, Duriez PJ, Hargreaves PG, Cragg MS, Beers SA.
    Blood; 2015 Mar 19; 125(12):1901-9. PubMed ID: 25631769
    [Abstract] [Full Text] [Related]

  • 4. Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.
    Da Roit F, Engelberts PJ, Taylor RP, Breij EC, Gritti G, Rambaldi A, Introna M, Parren PW, Beurskens FJ, Golay J.
    Haematologica; 2015 Jan 19; 100(1):77-86. PubMed ID: 25344523
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.
    Church AK, VanDerMeid KR, Baig NA, Baran AM, Witzig TE, Nowakowski GS, Zent CS.
    Clin Exp Immunol; 2016 Jan 19; 183(1):90-101. PubMed ID: 26307241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of complement-dependent cytotoxicity by linking factor-H derived short consensus repeats 19-20 to CD20 antibodies.
    Prantl L, Heider P, Bergmeister L, Calana K, Bohn JP, Wolf D, Banki Z, Bosch A, Plach M, Huber G, Schrödel S, Thirion C, Stoiber H.
    Front Immunol; 2024 Jan 19; 15():1379023. PubMed ID: 39104533
    [Abstract] [Full Text] [Related]

  • 9. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL, Koefoed K, Geisler C, Gadeberg OV, Frank DA, Petersen J, Jurlander J, Pedersen MW.
    Br J Haematol; 2013 Oct 19; 163(2):182-93. PubMed ID: 23927424
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties.
    Rafiq S, Butchar JP, Cheney C, Mo X, Trotta R, Caligiuri M, Jarjoura D, Tridandapani S, Muthusamy N, Byrd JC.
    J Immunol; 2013 Mar 15; 190(6):2702-11. PubMed ID: 23418626
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
    Winiarska M, Bojarczuk K, Pyrzynska B, Bil J, Siernicka M, Dwojak M, Bobrowicz M, Miazek N, Zapala P, Zagozdzon A, Krol M, Syta A, Podszywalow-Bartnicka P, Pilch Z, Dabrowska-Iwanicka A, Juszczynski P, Efremov DG, Slabicki M, Zenz T, Le Roy A, Olive D, Rygiel TP, Leusen JH, Golab J.
    MAbs; 2014 Mar 15; 6(5):1300-13. PubMed ID: 25517315
    [Abstract] [Full Text] [Related]

  • 13. Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies.
    Duong MN, Matera EL, Mathé D, Evesque A, Valsesia-Wittmann S, Clémenceau B, Dumontet C.
    MAbs; 2015 Mar 15; 7(1):192-8. PubMed ID: 25523586
    [Abstract] [Full Text] [Related]

  • 14. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB.
    Clin Cancer Res; 2008 Jul 15; 14(14):4650-7. PubMed ID: 18628480
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.
    Bowles JA, Wang SY, Link BK, Allan B, Beuerlein G, Campbell MA, Marquis D, Ondek B, Wooldridge JE, Smith BJ, Breitmeyer JB, Weiner GJ.
    Blood; 2006 Oct 15; 108(8):2648-54. PubMed ID: 16825493
    [Abstract] [Full Text] [Related]

  • 16. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
    Robak T, Robak E.
    BioDrugs; 2011 Feb 01; 25(1):13-25. PubMed ID: 21090841
    [Abstract] [Full Text] [Related]

  • 17. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
    Kinder M, Greenplate AR, Strohl WR, Jordan RE, Brezski RJ.
    MAbs; 2015 Feb 01; 7(3):494-504. PubMed ID: 25933349
    [Abstract] [Full Text] [Related]

  • 18. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
    Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF.
    Breast Cancer Res Treat; 1999 Feb 01; 53(3):199-207. PubMed ID: 10369066
    [Abstract] [Full Text] [Related]

  • 19. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A, Hasenkamp J, Engelke M, Burkhart N, Trümper L, Wienands J, Glass B.
    Exp Hematol; 2010 Mar 01; 38(3):213-21. PubMed ID: 20056126
    [Abstract] [Full Text] [Related]

  • 20. A real-time antibody-dependent cellular phagocytosis assay by live cell imaging.
    Shi Y, Sun Y, Seki A, Rutz S, Koerber JT, Wang J.
    J Immunol Methods; 2024 Aug 01; 531():113715. PubMed ID: 38936465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.